Press center

"And God forbid you read Kirov newspapers before lunch!" An open letter from the General Director of JSC "AVVA RUS" to the Editor-in-Chief of the Kirov newspaper "Reporter".

On the eve of the passing year 2016, on behalf of the company's shareholders and personally from myself, I would like to express my deep gratitude for the fact that we have been together through this challenging year.

Nonna Grishaeva, Honored Artist of the Russian Federation, congratulates the employees of JSC "AVVA RUS" and PJSC "OTISIFARM" on the upcoming 2017 New Year.

On December 23, Russian Minister of Education and Science Olga Vasilyeva met with the winners of international school student olympiads who were part of the Russian national teams. Among them was Alexander Artemyev from Kirov, now a student at the Moscow Institute of Physics and Technology.

Companies "NatsimBio" (a subsidiary of Rostec State Corporation), Kedrion Biopharma (Italy), and "Pharmstandard" have signed a memorandum on the joint implementation of projects in the field of blood plasma drug production.

JSC "AVVA RUS" has successfully passed recertification for compliance of its quality management system with the requirements of ISO 9001:2015 at VNIIS, receiving a new certificate as a result.

TV feature from the 'Ok, Kirov' program on the 'STS' channel

On December 21, the FAS prepared amendments to Federal Law No. 61-FZ "On the Circulation of Medicinal Products," defining the rules and methods for creating a registry of interchangeable medicinal drugs that will compete with each other in tenders.

Indian Sun Pharma has closed the deal to acquire 85.1% of the shares of JSC Biosintez, according to a statement from Sun Pharma on the Bombay Stock Exchange. Previously, the main owner of the Penza-based Biosintez was Boris Shpigel's Biotek Group.

The U.S. Department of Justice has filed charges against former CEO of the pharmaceutical company Hermitage Pharmaceutical Inc., Jeffrey Gleser, and former president of the company, Jason Malek, who are suspected of colluding with other drug manufacturers to maintain inflated prices for antibiotics and diabetes medications, according to Bloomberg News.

Japanese Fujifilm Holdings Corp has announced the acquisition of a 70% stake in the chemical company Wako Pure Chemical Industries from the pharmaceutical company Takeda Pharmaceutical for 198.5 billion yen ($1.7 billion).

Japanese corporation Mitsui & Co and Russian pharmaceutical company R-Pharm have signed an agreement for the acquisition of a 10% stake in the Russian holding.